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ABSTRACT
Goals of Work
To develop recommendations for effective commu-
nication between cancer health care providers and 
patients based on a systematic review of methods 
of clinician–patient communication that may affect 
patient outcomes associated with distress at critical 
points in the course of cancer care.
Materials and Methods
A systematic review of the literature was conducted, 
and evidence-based recommendations were formu-
lated to guide clinician–patient communication in 
cancer care. A formal external review was conducted 
to validate the relevance of these recommendations.
Main Results
Recommendations for communication in cancer care 
are presented, based on
●    guidelines from the Australian National Breast 
Cancer Centre and the Australian National Cancer 
Control Initiative,
●    an updated systematic review of the research 
evidence, and
●    a consensus by the Clinician–Patient Communica-
tions Working Panel of the Program in Evidence-
Based Care of Cancer Care Ontario.
The recommendations were sent to 110 Ontario 
practitioners for external review: 33 responded (30% 
response rate). Most of these respondents (87%) 
agreed with the draft recommendations and ap-
proved of their use as a practice guideline (90%). A 
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condensed version of the recommendations, including 
10 key points, was also created.
Conclusions
There is evidence to support general clinician–patient 
communication approaches, although the preferences 
of cancer patients regarding such communication 
exhibit individual and cultural variability. Recom-
mendations are provided, based on evidence, the 
consensus of an expert panel, and feedback from a 
survey of external practitioners. Evidence evaluating 
the role of decision aids and strategies to facilitate 
better communication is inconsistent, although such 
tools may be of value for some patients.
KEY WORDS
Practice guideline, systematic review, cancer, com-
munication, relationships
1.  INTRODUCTION
A relationship of health care providers with patients, 
based on trust, respect, and reciprocity, and with 
mutually negotiated goals and expectations, can be 
an important support and buffer for cancer patients 
experiencing distress. Communication serves to build 
and maintain this relationship, to transmit informa-
tion, to provide support, and to negotiate treatment 
decisions. The process of communication between 
providers and cancer patients can significantly af-
fect clinical outcomes 1. However, recent evidence 
demonstrates that communication in cancer care 
may often be suboptimal, particularly with regard to 
the emotional experience of the patient 2. The aim of 
the present paper is to present recommendations for 43
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effective clinician–patient cancer-related communica-
tion during consultation visits, which may prevent or 
alleviate patient distress. We hope that the recommen-
dations will help to promote empathic and effective 
communication in medical and cancer care settings.
Cancer Care Ontario’s Program in Evidence-
Based Care (pebc) is a provincial initiative respon-
sible for developing evidence-based clinical practice 
guidelines (cpgs) in Ontario. The pebc guidelines are 
used to facilitate effective practice, to guide provin-
cial and institutional policy, and to enable access to 
treatments in the publicly funded provincial health 
care system 3–5. The pebc is one component of a larger 
formalized cancer system defined by data about, and 
monitoring of, system performance; evidence-based 
knowledge and best practices; transfer and exchange 
of such knowledge; and strategies to leverage imple-
mentation of knowledge. Methods used by the pebc 
include the systematic review of research evidence by 
teams comprising clinical, content, and methodology 
experts; interpretation of, and team consensus about, 
the evidence; development of recommendations; 
and formal standardized external review of all draft 
cpgs 3,4,6–9. The external review process involves 
disseminating draft  cpgs and a validated survey, 
Clinician’s Assessments of Practice Guidelines in 
Oncology, to a sample of clinicians for whom the cpg 
is relevant 6. To create an appropriate sample, defining 
features of the cpg (topic, modality of care, disease 
site) are matched with professional characteristics of 
clinicians and content experts held in a comprehen-
sive database of clinicians involved in cancer care in 
the province. Reminders are sent to non-responders 
at 2 weeks (postcard) and at 4 weeks (second full 
package), with closure of the review process typically 
occurring between weeks 7 and 8.
Using the foregoing methods, the clinical rec-
ommendations presented here were developed by 
the Clinician–Patient Communications Working 
Panel of the pebc of Cancer Care Ontario. The rec-
ommendations are based on a systematic review of 
cancer-related communication, which is available in 
a companion document 10. This systematic review is 
a convenient source of the best evidence currently 
available on clinician–patient communication relating 
to critical points of care (cancer diagnosis, recurrence 
or metastatic disease, and end of life) and its effect on 
patient distress. The recommendations are intended 
to promote evidence-based practice and to improve 
quality of care for patients.
2.  MATERIALS AND METHODS
2.1  Systematic Review
The systematic review was conducted by the 
Clinician–Patient Communications Working Panel 
of the pebc 3,4. The methods are described in detail 
in another publication 10. Evidence-based practice 
guidelines with explicit literature selection criteria, 
systematic reviews, meta-analyses, and randomized 
trials were all eligible for the review. The quality 
of the guidelines, randomized trials, and systematic 
reviews was assessed using standardized criteria for 
each type of publication.
2.2  Development of Evidence-Based Recommendations
After the systematic review, the Clinician–Patient 
Communications Working Panel developed evidence-
based recommendations. The review was completed 
in 2007, and the guidelines were completed in 2008. 
A decision was made to use the Australian National 
Breast Cancer Centre and the Australian National 
Cancer Control Initiative (nbcc-ncci), Clinical Practice 
Guidelines for the Psychosocial Care of Adults with 
Cancer 11 as a framework for the recommendations, 
supplemented by additional information from the 
systematic review. Based on this framework, general 
evidence-based recommendations are provided first, 
followed by more specific recommendations related to 
the stage in the diagnostic or treatment process.
The recommendations developed by the Working 
Panel were sent to Ontario cancer practitioners for 
external review. Practitioner feedback was obtained 
through a mailed survey of 110 participants in Ontario, 
including nurses, social workers, patient educators, 
palliative care physicians, psychiatrists, psychologists, 
oncologists, surgeons, and family physicians. The ex-
ternal review group also included members of the Pro-
vincial Palliative Care Committee and the Provincial 
Psychosocial Oncology Committee. The survey items 
asked respondents to evaluate the methods, results, and 
discussion used to inform the draft recommendations. 
Respondents were then asked to indicate whether the 
draft recommendations should be approved as a guide-
line. Written comments were invited. The Clinician–
Patient Communications Working Panel reviewed the 
results of the survey, and consensus in this expert group 
was achieved by teleconference discussion. There was 
no instance in which external consultation was needed 
to achieve consensus.
3.  RESULTS
3.1  External Review
From among the 110 surveys sent, 33 responses were 
received (30% response rate). Responses include 
returned completed surveys, and telephone, fax, and 
e-mail responses. Of the respondents, 60% were 
nurses; 17%, surgeons; 11%, family physicians; 6%, 
medical oncologists; and 3% each, patient educa-
tors and medical physicists. Of the participants who 
responded, 31 (94%) indicated that the report was 
relevant to their practice or organizational position, 
and of those 31, 26 (84%) agreed with the summary 
of evidence, 27 (87%) agreed with the recommenda-44
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tions, and 28 (90%) approved of the recommendations 
as a practice guideline.
3.2  Summary of Main Findings
Almost all respondents agreed with the recommen-
dations, and 20 respondents (61%) provided written 
comments, some suggesting changes to the guideline. 
Several respondents remarked that professional trans-
lation services and not hospital staff, family, or volun-
teers should be used to translate important information 
during clinical interviews. Others suggested that more 
information should be included regarding methods to 
address the differences in communication preferences 
between patients from various cultures. One respon-
dent recommended that the guideline should include 
having a conversation about disease progression be-
fore the transition to end-of-life care begins. And one 
practitioner commented that a condensed version of 
the recommendations would be useful.
3.3  Modifications and Actions by the Clinician– 
Patient Communications Working Panel
The nbcc-ncci Clinical Practice Guidelines for the Psy-
chosocial Care of Adults with Cancer were selected as a 
framework for this area of practice. The recommenda-
tions that follow reflect integration of the nbcc-ncci 
recommendations, an updated systematic review of 
research evidence since the release of those guide-
lines, and consensus among the Clinician–Patient 
Communications Working Panel members. Based 
on the comments obtained from practitioners during 
the external review, recommendations were added 
suggesting that the provider consider the patient’s spe-
cific cultural needs and preferences, use professional 
translation services when possible, and consider the 
patient’s ability to communicate in English. As well, 
the term “end of life” was changed to “disease pro-
gression” to reflect the request to begin conversa-
tions before end-of-life care begins. Furthermore, a 
10-point summary of important elements to consider 
when communicating with patients was created.
4.  RECOMMENDATIONS
The recommendations that follow were based on 
evidence that met nbcc-ncci evidence grading levels i 
and ii—that is, they were obtained from systematic 
reviews of all relevant randomized controlled trials 
(rcts) or from at least one properly designed rct. 
This evidence-based rationale for the recommenda-
tions is summarized in each of the sections, followed 
by the specific recommendations that flow from that 
rationale. The focus in these recommendations is on 
the process of communication at specific stages in 
the disease and treatment trajectory, rather than on 
the content of the communication.
4.1  General Interaction Skills
4.1.1  Evidence-Based Rationale
The way in which clinicians and the treatment team 
relate to and communicate with patients can benefit 
those patients and their families by improving aspects 
of psychosocial adjustment, decision-making, treat-
ment compliance, and satisfaction with care.
Aspects of communication that are important 
include empathic listening and creating an environ-
ment in which patients are free to express feelings 
and ask questions.
Understanding, recall, and satisfaction with care 
may increase when techniques are used to reinforce 
or record what has been communicated to patients. 
These techniques may include taping consultations, 
providing general information tapes, sending sum-
mary letters as a follow-up to consultation, and in-
cluding a support person in the clinical visit.
4.1.2  Recommended Approach: General Interaction 
Skills
The skills outlined here are considered important in 
any consultations or interactions with patients with 
cancer at any stage of the disease:
●    Providing supportive communication
●    Identifying, and adhering to, the stated prefer-
ences of the patient in the approach to information 
exchange and decision-making
●    Providing the opportunity for the patient to have 
the company of a support person during the con-
sultation, and informing the patient about this 
opportunity in advance of the visit
●    Showing regard and concern through the use of 
verbal and nonverbal behaviour that is appropri-
ate for the patient’s age, cultural background, and 
preferences
●    Using active empathic listening, facilitating re-
sponses by the patient
●    Allowing the patient to express any concerns, 
fears, anxieties, or anger in a manner that aligns 
with the communication preferences of the patient 
at the time—for example, with regard to talking 
or crying
●    Discussing embarrassing or disturbing topics in 
a manner that aligns with the communication 
preferences of the patient
●    Offering access to appropriate psychosocial sup-
port services
●    Communicating in understandable language
●    Assessing the current understanding of the patient 
before providing additional information
●    Explaining difficult terms and avoiding medical 
jargon
●    When possible, using professional translation 
services, rather than hospital staff, volunteers, or 
family members
●    Using strategies to aid recall and understanding45
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●    Providing the opportunity for the patient to ask 
questions and seek understanding
●    When appropriate, making use of simple diagrams 
and pictures
●    Repeating and summarizing important informa-
tion
●    Reinforcing important information by using one 
or more of the following aids, if appropriate:
  ●    Relevant information provided in written 
form
  ●    A tape of the consultation, as needed and if 
wanted
  ●    A summary letter sent to the patient as follow-
up
4.1.3  Recommended Approach: Common Skills Across 
Critical Points of Care
In addition to the general interaction skills described 
in the preceding subsection, these steps are recom-
mended when telling patients that they have cancer, 
a recurrence, or metastases:
●    Before a discussion about diagnosis, recurrence, 
or metastases:
  ●    Ensure that the news is given in person and in 
a quiet, private place. Allow enough uninter-
rupted time. When communication in person 
is not possible, ensure that the patient is well 
supported before disclosure is made.
  ●    Encourage the presence of a second relevant 
person, if appropriate.
  ●    Make available other methods to convey 
additional information, including written 
materials, or videotapes or audiotapes of 
consultations, based on patient or family 
request.
●    When giving information on diagnosis, recur-
rence, or metastases:
  ●    Assess the patient’s personal preferences for 
information and current understanding of 
their condition. For example, ask “Tell me, in 
your own words, what you understand about 
your condition?”
  ●    Briefly explain the process by which the 
diagnosis was reached.
  ●    Provide information simply and honestly, 
using lay terms rather than euphemisms.
  ●    Avoid giving the message that “nothing can 
be done.”
  ●    Clearly indicate that you will make recom-
mendations about the range of acceptable 
care options, but that you are willing to be 
involved in ongoing care (if required), no 
matter what decision is made by the patient 
in response to the recommendations, and that 
patient consent is required to proceed with 
any care option.
  ●    Play an emotional and supportive role by 
giving the patient the opportunity to express 
concerns and feelings (including fears, anger, 
or anxieties) and to cry freely. Respond em-
pathically to the patient’s communications.
  ●    Address disturbing or embarrassing topics in 
a manner that aligns with the patient’s prefer-
ences.
  ●    In concluding the discussion, summarize the 
main points of the consultation and assess the 
understanding that the patient has acquired 
about the information that has been commu-
nicated.
  ●    Ask if there is anything more that the patient 
would like to discuss.
  ●    Offer to assist in telling others about any dif-
ficult news.
  ●    Indicate your availability to address any 
questions or concerns, and arrange a further 
appointment to review the situation within a 
specified period (for example, within 24 hours 
to 2 weeks).
  ●    Assess the understanding of the patient about 
their prognosis.
●    After a discussion of a diagnosis, recurrence, or 
metastases:
  ●    Document any information given to the pa-
tient and family members.
  ●    Let others, particularly the general practitio-
ner caring for the patient, know in a timely 
manner the extent of the information given 
and your perception of the understanding of 
that information by the patient.
  ●    Ensure that there is a provider with whom the 
patient can debrief after the interaction.
4.2  How to Discuss Prognosis
4.2.1  Evidence-Based Rationale
The way in which a prognosis is communicated—for 
example, the use of words or numbers, the discussion 
of survival or death as the outcome—and the time 
taken to explain information can influence emotional 
reactions in patients and decisions by those patients 
about treatment.
4.2.2  Recommended Approach
These steps are recommended in conjunction with 
the general interaction skills for discussing prognosis 
with people with cancer:
●    In offering prognostic information:
  ●    First, ask if the patient wants information 
about prognosis (for example, “I can tell you 
what happens to most people in your situa-
tion. Would you like me to do that?”), what 
the patient’s current understanding about 
prognosis is, and what kind of information 
the patient expects to receive.
  ●    Offer prognostic information as part of treat-
ment decision-making before selecting and 
commencing treatment.
●    In discussing aspects of prognosis:46
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  ●    Adhere to the patient’s stated preferences for 
prognostic information at that time. If or when 
such information is desired, the following 
details can be provided:
    ○    Staging and its implications for progno-
sis
    ○    Chances of being cured or that cancer will 
never return
    ○    Likely benefits and risks of treatment
    ○    Average and longest survival times, em-
phasizing a range rather than a single time 
point
●    Manner of discussing prognosis:
  ●    Preface any prognostic estimate with its limi-
tations:
    ○    Explain that you cannot predict with 
certainty how individual patients will 
respond to the illness and its treatment.
    ○    Provide an initial prognosis, based on 
available information, and explain how 
this prognosis may be revised by addi-
tional information. Suggest a time frame 
for when additional prognostic informa-
tion is likely to be available.
  ●    Use mixed framing:
    ○    Give chances of cure first and then 
chances of relapse.
  ●    Present information in a variety of media—
words, statistics, graphs—as needed.
  ●    Combine verbal estimates: for example, 
“small chance” with numeric estimates.
  ●    Provide verbal explanations of survival graphs.
  ●    When explaining relative risk reduction, pro-
vide several examples of the calculations.
  ●    Use only statistical terminology such as me-
dian, hazard ratio, or relative risk, if patients 
are familiar with these concepts.
●    In concluding the discussion:
  ●    Provide information that has hope-giving 
potential, including ongoing care that the 
patient will receive.
  ●    Provide information that is necessary for the 
patient to plan for the future.
  ●    Assess the understanding of the patient con-
cerning personal prognosis.
4.3  How to Prepare Patients for Medical Procedures
4.3.1  Evidence-Based Rationale
Providing patients with information about the 
procedure that they are about to undergo reduces 
emotional distress and improves psychological and 
physical recovery.
Practical details about the procedure (procedural 
information), communicated in person or through 
booklets, videotapes, or compact discs, may reduce 
psychological distress. This information can be pro-
vided by a clinician or other health professional such 
as a specialist nurse.
Information about the experiences that patients 
are likely to have before, during, and after a procedure 
(sensory information) decreases anxiety.
Psychosocial support before undergoing surgery 
reduces psychological distress.
4.3.2  Recommended Approach for Preparation for 
Medical Procedures
These steps, in conjunction with the general inter-
action skills listed earlier, are recommended to ad-
equately prepare patients for a medical procedure:
●    Before the procedure:
  ●    Ask how much detail the patient would like 
to know about the procedure before you 
explain it.
  ●    Based on the stated preferences of the patient, 
explain why the procedure is needed and what 
outcome is expected.
  ●    Explain the possible benefits and risks in-
volved with the procedure.
  ●    Provide information regarding the actual 
performance of the procedure, which may 
include these aspects:
    ○    Where the procedure is likely to take place 
and who will perform it
    ○    Any tests needed before the procedure
    ○    What the patient will need to do before 
the procedure
    ○    What the patient is likely to experience 
during and after the procedure
    ○    How any discomfort will be managed 
for the patient before and after the pro-
cedure
  ●    Provide an opportunity for the patient to talk 
about concerns such as embarrassment, pain, 
fear, or death.
●    During the procedure:
  ●    Offer to provide information about what will 
be done and how it will feel.
  ●    Provide the patient with the level of control 
that this patient feels most comfortable with 
(for example, asking the patient to say when 
he or she is ready to begin may be appropriate 
in some cases).
●    After the procedure:
  ●    Encourage the patient to state needs, and 
reframe complaints into requests.
  ●    Discuss the recovery period and limitations 
on activities of daily living.
4.4  How to Discuss Treatment Options
4.4.1  Evidence-Based Rationale
Appropriate and detailed information promotes 
understanding and increases the psychological well-
being of people with cancer.
Recall of information increases when patients are 
provided with individualized information.47
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Providing a question prompt sheet to cancer pa-
tients during an initial consultation may promote their 
questions. It also reduces anxiety, improves recall, 
and shortens the consultation.
4.4.2  Recommended Approach for Discussing  
Treatment
These steps, in conjunction with the general interac-
tion skills listed earlier, are recommended for discuss-
ing treatment options:
●    In providing information about treatment:
  ●    Explain to the patient, in lay terms, the treat-
ment options that are available (including no 
cancer-directed treatment), and ask how much 
detail the patient would like to receive about 
each option.
  ●    Tailor the information to the needs and 
preferences of the patient for information 
content and detail. Include a discussion of the 
expected outcomes and major side effects of 
each treatment option.
  ●    Acknowledge the uncertainty that any treatment 
will achieve its aim. Summarize and explain the 
pros and cons of each treatment option.
  ●    Offer a variety of media providing informa-
tion about treatment options: written informa-
tion, decision aids, videotapes, audiotapes, or 
memory discs of consultations.
  ●    Ask whether the patient has any questions 
about alternative and complementary thera-
pies.
  ●    Ask if the patient has concerns to express or 
questions to ask about the various options.
●    In making decisions about treatment:
  ●    Explore at an early stage how the patient 
would like to be involved in decision-making, 
and adhere to the wishes expressed.
  ●    Be aware that the patient’s preferences may 
change over time. Regularly check the nature 
and level of participation that this patient 
would like to have in decision-making.
  ●    Ask the patient about personal values and 
life circumstances in relation to the treatment 
options.
  ●    Use inclusive language such as “we” and 
“our.”
  ●    Make explicit that the patient has choices to 
make and that personal involvement in those 
choices is important.
  ●    If the patient is unaccompanied, ask whether a 
discussion of treatment options with family or 
friends would be appreciated. Tell the patient 
that these individuals can have an opportunity 
to be involved in treatment decisions, if the 
patient so desires.
  ●    Assure the patient that there is enough time 
to consider treatment options. Offer to ar-
range a return visit when the patient has 
made a decision.
●    In playing an emotional and supportive role:
  ●    Consider the specific needs related to the 
patient’s sex, age, and culture.
  ●    Offer the patient an opportunity to discuss and 
express concerns and feelings (including fears, 
anger, hopes, anxieties) and to cry freely.
  ●    Acknowledge individual differences in emo-
tional impact.
  ●    Make your own recommendations about the 
range of acceptable treatments, but also ex-
press a willingness to be involved in ongoing 
care (if required), no matter what decision 
the patient makes in response to your recom-
mendations.
●    In concluding the discussion:
  ●    Offer assistance in telling others any difficult 
news about treatment choices.
●    After discussing treatment options:
  ●    Document information given to the patient 
and family members.
  ●    Let others, particularly the general practitioner 
caring for the patient, know the extent of the 
information given and your perception of the 
patient’s understanding of that information.
4.5  Recommended Approach for Discussing Disease 
Progression
These steps, in conjunction with the general interac-
tion skills described earlier, are recommended to 
prepare patients for progression of disease:
●    Provide information openly and honestly about 
changes in the cancer, about treatment efficacy, 
and when requested, about prognosis.
●    Offer the opportunity for the patient to voice 
concerns and goals before you discuss specific 
clinical decisions.
●    Ask open-ended questions, such as these:
  ●    What concerns you most about your illness?
  ●    What has been most difficult about this illness 
for you?
  ●    What are your hopes and expectations and 
fears about the future?
  ●    As you think about the future, what is the 
most important to you?
  ●    Is faith (religion, spirituality) important to you 
in this illness? Can you describe the way in 
which it is important?
  ●    Would you like to explore these matters with 
someone?
●    When concerns have been discussed, provide 
reassurance about issues such as symptom man-
agement and, when possible, the availability of 
expert palliative care.
●    Offer the opportunity to fully explore how the 
patient understands palliative care. Emphasize 
the role of palliative care throughout illness.
●    Clearly assure the patient that optimal care will be 
provided and that they will not be abandoned.48
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●    In planning care:
  ●    Assess the abilities and willingness of the 
patient to be involved in decision-making. 
Identify a substitute decision-maker, if nec-
essary. Check with the patient and the fam-
ily members about the amount and type of 
information desired.
  ●    Discuss the usual need for greater family 
involvement when the awareness and com-
munication capacities of the patient decrease 
with disease progression.
  ●    Keep the patient—and when permission has 
been obtained, the family—informed about 
issues that are most important to them, such 
as the likely course of the disease, symptom 
management, and service availability.
  ●    Ask about what the patient understands about 
their disease status, including current needs 
and priorities.
  ●    Discuss a plan for future management and 
monitoring, including an understanding of 
short- and medium-term outcome goals. 
Review plans and wishes for advanced care 
with the patient or the family, or both.
●    In dealing with physical issues:
  ●    Introduce the notion of active treatment of 
symptoms and the importance to ongoing 
care of treating symptoms.
  ●     Discuss and clarify the current targets of 
symptom management. Actively inquire 
about the patient’s symptoms.
  ●     Provide the patient and the family with infor-
mation about specific measures available for 
symptom relief.
●    In dealing with psychological issues:
  ●     Offer the opportunity to discuss how the 
patient and the family are coping with the 
disease and how the reactions of others to 
the disease are affecting the well-being of the 
patient.
  ●     Make specific arrangements for counselling 
and support or information to be provided 
to the patient and the family by specialized 
psychosocial oncology staff, when appropri-
ate and when such services are available.
●    In dealing with social issues:
  ●    Allow an opportunity for open communication 
and expression by the patient of feelings and 
fears in relationships, and for discussions with 
family and friends related to dying and death.
  ●    Address, in a timely and sensitive manner, prac-
tical issues such as planning for care and support 
at home, making a will, designating power of 
attorney, and applying to palliative care units.
5.  CONCLUSIONS
Clinician–patient communication is a fundamental 
aspect of cancer care that significantly affects the 
therapeutic relationship, the well-being of patients and 
families, treatment decision-making and compliance, 
and the capacity of patients and families to plan for al-
ternative trajectories in the disease and treatment course. 
However, despite its importance, clinician–patient 
communication has been underemphasized in medical 
education and is often inadequate in cancer care.
Here, we have presented guidelines for com-
munication in cancer care that were developed by 
an expert panel, based on a systematic review of the 
literature 3,4,10, and validated by a survey of external 
practitioners. The results are limited by the evidence 
that is currently available and by the relatively low 
response rate from the external practitioners. Nev-
ertheless, the recommendations received almost 
universal endorsement from those practitioners who 
did respond. We hope that these recommendations, 
including the key points highlighted in Table i, will 
be useful guideposts for the teaching and practice of 
communication in cancer care. Further research is 
needed to establish the most satisfactory methods of 
communication, to evaluate the role of Web-based and 
other technologies in communication, and to develop 
and evaluate more effective methods of education and 
training in medical communication.
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table i  Ten key points for clinician–patient communication
1 Take into account the needs and preferences of patients, including those related to religion and culture, in the communication dialogue.
2 Identify and adhere to the stated preferences of patients in the approach to information exchange and decision-making.
3 Show regard and concern for patients by using verbal and nonverbal behaviour that is appropriate for their age, cultural back-
ground, and personal preferences.
4 Ensure that significant news is given in person and in a quiet, private place. Allow enough uninterrupted time.
5 Communicate information honestly, but in a way that provides room for hope and that indicates your willingness to be there for 
ongoing support.
6 Consider strategies to aid recall and understanding—that is, allow questions, use diagrams, write down or tape the consultation.
7 Allow patients to express their understanding and feelings about the information provided.
8 Provide an opportunity for debriefing, discussion, and support after the communication of critical and upsetting information.
9 Communicate in clear, simple terms, avoiding medical jargon.
10 Allow for communication with patients individually and as a part of a family unit or support system.49
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